JP2005517449A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005517449A5 JP2005517449A5 JP2003569856A JP2003569856A JP2005517449A5 JP 2005517449 A5 JP2005517449 A5 JP 2005517449A5 JP 2003569856 A JP2003569856 A JP 2003569856A JP 2003569856 A JP2003569856 A JP 2003569856A JP 2005517449 A5 JP2005517449 A5 JP 2005517449A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- therapeutic agent
- neurological
- psychiatric
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35717902P | 2002-02-15 | 2002-02-15 | |
| PCT/US2003/004414 WO2003070965A2 (en) | 2002-02-15 | 2003-02-14 | The eaat2 promoter and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005517449A JP2005517449A (ja) | 2005-06-16 |
| JP2005517449A5 true JP2005517449A5 (https=) | 2006-03-23 |
Family
ID=27757583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003569856A Pending JP2005517449A (ja) | 2002-02-15 | 2003-02-14 | Ｅａａｔ２プロモーター及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7723505B2 (https=) |
| EP (1) | EP1474434B1 (https=) |
| JP (1) | JP2005517449A (https=) |
| AT (1) | ATE420176T1 (https=) |
| AU (1) | AU2003211040A1 (https=) |
| DE (1) | DE60325695D1 (https=) |
| WO (1) | WO2003070965A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ540288A (en) * | 2002-11-22 | 2009-06-26 | Univ Johns Hopkins | Target for therapy of cognitive impairment |
| US20040171108A1 (en) * | 2003-02-07 | 2004-09-02 | Fisher Paul B. | Human excitatory amino acid transporter-2 gene promoter and uses thereof |
| AU2004214938B2 (en) * | 2003-02-26 | 2008-11-06 | Johns Hopkins University | Glutamate transport modulatory compounds and methods |
| AU2004285473A1 (en) * | 2003-10-21 | 2005-05-12 | Johns Hopkins University | Neuroprotection with beta-lactam compounds |
| JP2005333845A (ja) * | 2004-05-25 | 2005-12-08 | Tokyoto Igaku Kenkyu Kiko | ミトコンドリア局在型ＤｓＲｅｄ２及びＥＣＦＰ発現ベクター |
| JP4586149B2 (ja) * | 2007-09-10 | 2010-11-24 | 長瀬産業株式会社 | プロモーターおよびその活性化方法 |
| US9719146B2 (en) * | 2009-09-09 | 2017-08-01 | General Electric Company | Composition and method for imaging stem cells |
| CN111956658B (zh) * | 2020-07-28 | 2023-04-28 | 中国医学科学院医药生物技术研究所 | miRNA 148簇作为诊断和/或治疗认知障碍相关疾病标志物的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5658782A (en) * | 1993-10-20 | 1997-08-19 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University A Non-Profit Organization | Amino acid transporters and uses |
| US7060457B2 (en) * | 1998-03-18 | 2006-06-13 | Johns Hopkins University | Aberrant glutamate transporters and methods of use |
| US20040166490A1 (en) | 2002-12-17 | 2004-08-26 | Morris David W. | Novel therapeutic targets in cancer |
| US20040171108A1 (en) | 2003-02-07 | 2004-09-02 | Fisher Paul B. | Human excitatory amino acid transporter-2 gene promoter and uses thereof |
-
2003
- 2003-02-14 US US10/480,179 patent/US7723505B2/en not_active Expired - Fee Related
- 2003-02-14 JP JP2003569856A patent/JP2005517449A/ja active Pending
- 2003-02-14 EP EP03742740A patent/EP1474434B1/en not_active Expired - Lifetime
- 2003-02-14 WO PCT/US2003/004414 patent/WO2003070965A2/en not_active Ceased
- 2003-02-14 DE DE60325695T patent/DE60325695D1/de not_active Expired - Fee Related
- 2003-02-14 AU AU2003211040A patent/AU2003211040A1/en not_active Abandoned
- 2003-02-14 AT AT03742740T patent/ATE420176T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ohki et al. | Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration | |
| Kahle et al. | Hyperphosphorylation and insolubility of α‐synuclein in transgenic mouse oligodendrocytes | |
| Eriksen et al. | Progranulin: normal function and role in neurodegeneration | |
| Pasinetti et al. | Clusterin (SGP‐2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain | |
| JP2005517449A5 (https=) | ||
| JP2005508165A5 (https=) | ||
| Blume et al. | BACE1 inhibitor MK-8931 alters formation but not stability of dendritic spines | |
| US20230165906A1 (en) | Compositions and methods for using transplanted microglia as a vehicle for widespread delivery of cells and other biologic agents to the brain | |
| Sugama | Stress-induced microglial activation may facilitate the progression of neurodegenerative disorders | |
| Liu et al. | Molecular mechanisms and therapeutics for SCA17 | |
| Koppel et al. | Tissue-specific and neural activity-regulated expression of human BDNF gene in BAC transgenic mice | |
| JP2008538775A5 (https=) | ||
| Daoutsali et al. | Antisense oligonucleotide-induced amyloid precursor protein splicing modulation as a therapeutic approach for Dutch-type cerebral amyloid angiopathy | |
| Kim et al. | Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice | |
| JP2024540537A5 (https=) | ||
| Syc-Mazurek et al. | Transcriptional control of retinal ganglion cell death after axonal injury | |
| WO2006063247A3 (en) | Regulated expression of transgenes in the central nervous system of mammals | |
| Propst et al. | Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene. | |
| Kwak et al. | Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research | |
| Redensek et al. | Expression and detrimental role of hematopoietic prostaglandin D synthase in spinal cord contusion injury | |
| JP2002535334A5 (https=) | ||
| Rodríguez-Campuzano et al. | Yin yang 1: function, mechanisms, and glia | |
| JP2003500466A5 (https=) | ||
| CN101426501A (zh) | β-氨基醇用于治疗炎性病症和疼痛的用途 | |
| Jacobs et al. | Targeted overexpression of a golli-myelin basic protein isoform to oligodendrocytes results in aberrant oligodendrocyte maturation and myelination |